Skip to main content
  • TiNO-Coated Stents Noninferior at 12 Months, Superior at 18 Months to EES in Preventing MACE in ACS Patients

    Cobalt-chromium-based titanium-nitride-oxide (TiNO)-coated stents were non-inferior to platinum-chromium-based biodegradable-polymer everolimus-eluting stents (EES) at 12 months and superior at 18 months with regard to major adverse cardiovascular events (MACE) in patients with acute coronary syndromes (ACS),  according to study results released Monday.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details